DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Stopeck A, Brufsky A, Kennedy L. et al
Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States.

J Med Econ 2020;
23 (01) 37-47

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: